Acquisition · Healthcare & Life Sciences

CureBay acquires Saveo pharma distribution unit to expand rural reach

By Startup Enthusiast · 18 March 2026

What they do

CureBay operates a full-stack rural healthtech platform connecting clinics with diagnostics and medicine supply chains

The company acquired Saveo's pharma distribution unit using existing funds to integrate partners across four states

This move integrates 10,000 Saveo partners into CureBay's 190 clinic network across Karnataka, Telangana, Andhra Pradesh, and Tamil Nadu

CureBay has acquired the pharma distribution unit of Saveo.
This strategic move aims to improve rural healthcare reach in India.
The acquisition was financed via existing funds without any new capital raise.
CureBay will integrate 10,000 Saveo partners into its clinic network.
The expanded network now spans Karnataka, Telangana, Andhra Pradesh, and Tamil Nadu.
This acquisition strengthens CureBay's position in the fragmented rural healthcare market.

The Indian rural healthcare market is estimated at $255 million in 2025.
The sector is projected to grow at a CAGR of 20.52% through 2034.
CureBay aims to reduce its break-even timeline to 12-15 months in denser markets.
Integration allows CureBay to leverage existing distribution infrastructure effectively.

CureBay provides a full-stack platform covering diagnostics, medicines, and referrals.
It offers consultations priced at ₹100 per session.
The Kavach subscription costs ₹499 annually for unlimited benefits.
The company operates in Odisha, Chhattisgarh, and Jharkhand currently.
It uses a 'circle' model with approximately 50 clinics per four districts.
CureBay reported revenue of ₹682 million in FY25.
The annual run rate reached ₹940 million recently.
The company plans expansion into Bihar and Uttar Pradesh over two years.

CureBay plans to expand into Bihar, eastern Uttar Pradesh, and Madhya Pradesh.
The company expects to achieve break-even in 12-15 months in new markets.
Expansion targets include Telangana and Andhra Pradesh over the next two years.

Elevar Equity (Lead) — Led CureBay's Series A round between 2022 and 2024.
Bertelsmann India Investments (Lead) — Co-led CureBay's Series B round in May 2025.
British International Investment (Co-Lead) — Co-led CureBay's Series B round in May 2025.

Product: A hybrid healthcare platform connecting rural patients with doctors, diagnostics, and medicine delivery.
Customers: Patients in underserved and rural areas of India requiring affordable healthcare services.
How it makes money: Charges for doctor consultations, medicine delivery, diagnostic tests, and annual health memberships.
What sets it apart: A hybrid online-and-physical model leveraging satellite health centers to provide last-mile primary care.